Business & FinanceHealth

Reuters exclusively reports Europe to accelerate trials of gene-engineered COVID-19 vaccines

Reuters exclusively reported that European officials aim to speed up trials for coronavirus vaccines containing genetically modified organisms, in a move that could help shots developed by companies like AstraZeneca and Johnson & Johnson. The plans are part of a wider EU strategy aimed at securing enough doses of a possible vaccine for the bloc as it fears lagging behind the United States and China.

Article Tags
Topics of Interest: Business & FinanceHealth
Type: Reuters Best
Sectors: Equities
Regions: Europe
Win Types: Exclusivity
Story Types: Exclusive / Scoop
Media Types: Text